Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer

scientific article published on 09 January 2013

Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/0008-5472.CAN-12-3040
P932PMC publication ID3688259
P698PubMed publication ID23302227

P50authorWenjun ChangQ59691345
P2093author name stringGuang Yang
Jianxiang Wang
Ki-Duk Song
Timothy C Thompson
Chengzhen Ren
Salahaldin A Tahir
Alexei Goltsov
P2860cites workActivation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cellsQ21142682
Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysisQ22252898
Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-cateninQ24299047
Understanding the Warburg effect: the metabolic requirements of cell proliferationQ24604760
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the wayQ28256465
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisQ28258638
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growthQ28262401
Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptorQ28272038
Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblastsQ28573519
Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinomaQ28749106
Critical nodes in signalling pathways: insights into insulin actionQ29614735
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activationQ29618700
Insulin and insulin-like growth factor signalling in neoplasiaQ29619495
Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistanceQ30479891
Caveolin; different roles for insulin signal?Q33215749
Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activityQ33611142
GSK3: a multifaceted kinase in Wnt signalingQ33712410
IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cellsQ33770174
Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression.Q33921157
Caveolin-1: a tumor-promoting role in human cancerQ34010128
Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.Q34986770
Metabolic alterations and targeted therapies in prostate cancerQ35401667
Rethinking WNT signalingQ35710664
Caveolin-1 in oncogenic transformation, cancer, and metastasisQ36030347
Roles and regulation of Wnt signaling and beta-catenin in prostate cancerQ36197343
Multiplicity of the interactions of Wnt proteins and their receptorsQ36692201
Tumor suppressors and cell metabolism: a recipe for cancer growthQ37390879
The role of caveolin-1 in prostate cancer: clinical implications.Q37542947
Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription.Q39329917
Insulin receptor expression by human prostate cancersQ39941083
Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signalingQ39964386
Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cellsQ40015373
Prostate cancer cells promote osteoblastic bone metastases through WntsQ40377933
Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp miceQ40440532
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancerQ40632123
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.Q40817530
Role of plasmalemmal caveolae in signal transduction.Q40835516
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosisQ40864791
Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signalingQ40866028
Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I.Q42437942
Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes.Q42800248
Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells?Q42858457
Fasting glucose is a risk factor for breast cancer: a prospective study.Q44217805
Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) StudyQ44763667
Caveolin, cholesterol and Ras signallingQ58444240
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cellsQ64381953
Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic markerQ73229791
Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activationQ73787446
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancerQ73893922
Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancerQ80620399
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
P304page(s)1900-1911
P577publication date2013-01-09
P1433published inCancer ResearchQ326097
P1476titleCaveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer
P478volume73

Reverse relations

cites work (P2860)
Q28534819Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer
Q38373132Baseline and Longitudinal Plasma Caveolin-1 Level as a Biomarker in Active Surveillance for Early Stage Prostate Cancer.
Q58573362Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis
Q31070165Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data
Q91709247Caveolin-1 Y14 phosphorylation suppresses tumor growth while promoting invasion
Q28072525Caveolin-1 in the regulation of cell metabolism: a cancer perspective
Q37564733Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer
Q24718293Caveolin-1 regulates lung cancer stem-like cell induction and p53 inactivation in carbon nanotube-driven tumorigenesis
Q26782615Caveolin-1, a stress-related oncotarget, in drug resistance
Q98778499Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer
Q92410949Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer
Q28547446Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Q28383915Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo
Q64069266MiR-1180 from bone marrow MSCs promotes cell proliferation and glycolysis in ovarian cancer cells via SFRP1/Wnt pathway
Q42226744Milk's Role as an Epigenetic Regulator in Health and Disease
Q47790660Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy.
Q37537958Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
Q47710385Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells
Q37735226Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells
Q34052780Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells
Q37555367Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease.
Q45419184The Glycolytic Switch in Tumors: How Many Players Are Involved?
Q47379977The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?
Q57106364The regulatory pathways leading to stem-like cells underlie prostate cancer progression
Q26766079The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
Q38263093WNT signaling: an emerging mediator of cancer cell metabolism?
Q49798174Wnt Signaling and Its Impact on Mitochondrial and Cell Cycle Dynamics in Pluripotent Stem Cells
Q38806302β-Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-κB Signaling Pathway